Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni?

Translated title of the contribution: Is it permissible to treat young diabetics with oral antidiabetics?

T. Halmos, L. Kautzky, A. Grósz, P. Pánczél, L. Gerö, G. Winkler

Research output: Contribution to journalArticle

Abstract

Authors analyzed the case history of 25 young diabetic patients, whose disease has been diagnosed before the age of thirty. The question that has been raised: is it allowed to treat young diabetics with oral drugs? By classifying the patients, they stated followings: In the 1. group they classified 16 verified MODY/NIDDY patients. In the second group they classified 3 young diabetics, whose disease had been evaluated as slowly progressing IDDM (autoimmune form). 3 patients belonged to the 3 group. They had been classified as MODY/NIDDY patients, however an extremely long lasting remission period--due to the short observation time--can not be excluded. The remaining 3 diabetic patients belonged to the IDDM group, with a long remission period. They were treated incorrectly with oral hypoglycemic drugs. Young diabetics can be treated with oral drugs only in case, when they are proven MODY/NIDDY patients. The precise differential diagnosis between this form and autoimmune IDDM, as well as long lasting remission periode, is extremely important.

Original languageHungarian
Pages (from-to)1245-1250
Number of pages6
JournalOrvosi Hetilap
Volume132
Issue number23
Publication statusPublished - Jun 9 1991

Fingerprint

Hypoglycemic Agents
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Pharmaceutical Preparations
Differential Diagnosis
Observation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Halmos, T., Kautzky, L., Grósz, A., Pánczél, P., Gerö, L., & Winkler, G. (1991). Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni? Orvosi Hetilap, 132(23), 1245-1250.

Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni? / Halmos, T.; Kautzky, L.; Grósz, A.; Pánczél, P.; Gerö, L.; Winkler, G.

In: Orvosi Hetilap, Vol. 132, No. 23, 09.06.1991, p. 1245-1250.

Research output: Contribution to journalArticle

Halmos, T, Kautzky, L, Grósz, A, Pánczél, P, Gerö, L & Winkler, G 1991, 'Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni?', Orvosi Hetilap, vol. 132, no. 23, pp. 1245-1250.
Halmos T, Kautzky L, Grósz A, Pánczél P, Gerö L, Winkler G. Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni? Orvosi Hetilap. 1991 Jun 9;132(23):1245-1250.
Halmos, T. ; Kautzky, L. ; Grósz, A. ; Pánczél, P. ; Gerö, L. ; Winkler, G. / Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni?. In: Orvosi Hetilap. 1991 ; Vol. 132, No. 23. pp. 1245-1250.
@article{44877a679b8b4043bde629e9fd8a2232,
title = "Szabad-e fiatal cukorbetegeket or{\'a}lis antidiabetikumokkal kezelni?",
abstract = "Authors analyzed the case history of 25 young diabetic patients, whose disease has been diagnosed before the age of thirty. The question that has been raised: is it allowed to treat young diabetics with oral drugs? By classifying the patients, they stated followings: In the 1. group they classified 16 verified MODY/NIDDY patients. In the second group they classified 3 young diabetics, whose disease had been evaluated as slowly progressing IDDM (autoimmune form). 3 patients belonged to the 3 group. They had been classified as MODY/NIDDY patients, however an extremely long lasting remission period--due to the short observation time--can not be excluded. The remaining 3 diabetic patients belonged to the IDDM group, with a long remission period. They were treated incorrectly with oral hypoglycemic drugs. Young diabetics can be treated with oral drugs only in case, when they are proven MODY/NIDDY patients. The precise differential diagnosis between this form and autoimmune IDDM, as well as long lasting remission periode, is extremely important.",
author = "T. Halmos and L. Kautzky and A. Gr{\'o}sz and P. P{\'a}ncz{\'e}l and L. Ger{\"o} and G. Winkler",
year = "1991",
month = "6",
day = "9",
language = "Hungarian",
volume = "132",
pages = "1245--1250",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "23",

}

TY - JOUR

T1 - Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni?

AU - Halmos, T.

AU - Kautzky, L.

AU - Grósz, A.

AU - Pánczél, P.

AU - Gerö, L.

AU - Winkler, G.

PY - 1991/6/9

Y1 - 1991/6/9

N2 - Authors analyzed the case history of 25 young diabetic patients, whose disease has been diagnosed before the age of thirty. The question that has been raised: is it allowed to treat young diabetics with oral drugs? By classifying the patients, they stated followings: In the 1. group they classified 16 verified MODY/NIDDY patients. In the second group they classified 3 young diabetics, whose disease had been evaluated as slowly progressing IDDM (autoimmune form). 3 patients belonged to the 3 group. They had been classified as MODY/NIDDY patients, however an extremely long lasting remission period--due to the short observation time--can not be excluded. The remaining 3 diabetic patients belonged to the IDDM group, with a long remission period. They were treated incorrectly with oral hypoglycemic drugs. Young diabetics can be treated with oral drugs only in case, when they are proven MODY/NIDDY patients. The precise differential diagnosis between this form and autoimmune IDDM, as well as long lasting remission periode, is extremely important.

AB - Authors analyzed the case history of 25 young diabetic patients, whose disease has been diagnosed before the age of thirty. The question that has been raised: is it allowed to treat young diabetics with oral drugs? By classifying the patients, they stated followings: In the 1. group they classified 16 verified MODY/NIDDY patients. In the second group they classified 3 young diabetics, whose disease had been evaluated as slowly progressing IDDM (autoimmune form). 3 patients belonged to the 3 group. They had been classified as MODY/NIDDY patients, however an extremely long lasting remission period--due to the short observation time--can not be excluded. The remaining 3 diabetic patients belonged to the IDDM group, with a long remission period. They were treated incorrectly with oral hypoglycemic drugs. Young diabetics can be treated with oral drugs only in case, when they are proven MODY/NIDDY patients. The precise differential diagnosis between this form and autoimmune IDDM, as well as long lasting remission periode, is extremely important.

UR - http://www.scopus.com/inward/record.url?scp=0026420512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026420512&partnerID=8YFLogxK

M3 - Article

C2 - 1852436

AN - SCOPUS:0026420512

VL - 132

SP - 1245

EP - 1250

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 23

ER -